发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 205 |
| Italy | 63 |
| GERMANY (FED REP GER) | 55 |
| France | 36 |
| Spain | 35 |
| England | 30 |
| CHINA MAINLAND | 23 |
| Greece | 20 |
| Japan | 15 |
| Canada | 14 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| MAYO CLINIC | 96 |
| HARVARD UNIVERSITY | 27 |
| UNIVERSITY OF TEXAS SYSTEM | 27 |
| HELMHOLTZ ASSOCIATION | 23 |
| RUPRECHT KARLS UNIVERSITY HEIDELBERG | 21 |
| UNIVERSITY OF FLORENCE | 21 |
| NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS | 20 |
| ASST PAPA GIOVANNI XXIII | 19 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 19 |
| DANA-FARBER CANCER INSTITUTE | 19 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Antibody-drug conjugate, GSK285 in relapsed/refractory m... | 58 |
| The 2016 WHO classification and diagnostic criteria for ... | 57 |
| Risk stratification of smoldering multiple myeloma incor... | 47 |
| Pathogenesis of bone disease in multiple myeloma: from b... | 41 |
| Interpreting clinical trial data in multiple myeloma: tr... | 34 |
| Phase I trial of isatuximab monotherapy in the treatment... | 26 |
| Exosomes play a role in multiple myeloma bone disease an... | 25 |
| Myelodysplastic syndromes current treatment algorithm 20... | 24 |
| Chronic lymphocytic leukemia treatment algorithm 2018 | 20 |
| Challenges in the introduction of next-generation sequen... | 19 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| BLOOD | 86 |
| CANCERS | 85 |
| LEUKEMIA | 78 |
| LEUKEMIA LYMPHOMA | 61 |
| BLOOD CANCER J | 53 |
| HAEMATOLOGICA | 53 |
| INT J MOL SCI | 53 |
| BLOOD ADV | 52 |
| CL LYMPH MYELOM LEUK | 49 |
| FRONT ONCOL | 47 |